<?xml version="1.0" encoding="UTF-8"?>
<ref id="bjh15394-bib-0020">
 <mixed-citation publication-type="journal" id="bjh15394-cit-0020">
  <string-name>
   <surname>Gupta</surname>, 
   <given-names>N.</given-names>
  </string-name>, 
  <string-name>
   <surname>Diderichsen</surname>, 
   <given-names>P.M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Hanley</surname>, 
   <given-names>M.J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Berg</surname>, 
   <given-names>D.</given-names>
  </string-name>, 
  <string-name>
   <surname>van de Velde</surname>, 
   <given-names>H.</given-names>
  </string-name>, 
  <string-name>
   <surname>Harvey</surname>, 
   <given-names>R.D.</given-names>
  </string-name> &amp; 
  <string-name>
   <surname>Venkatakrishnan</surname>, 
   <given-names>K.</given-names>
  </string-name> (
  <year>2017a</year>) 
  <article-title>Population pharmacokinetic analysis of ixazomib, an oral proteasome inhibitor, including data from the phase III TOURMALINE‐MM1 study to inform labelling</article-title>. 
  <source xml:lang="en">Clinical Pharmacokinetics</source>, 
  <volume>56</volume>, 
  <fpage>1355</fpage>–
  <lpage>1368</lpage>.
  <pub-id pub-id-type="pmid">28290121</pub-id>
 </mixed-citation>
</ref>
